ALPS Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,504	Closed	-$505K	–	1052
2025 Q4	$505K	Buy	8,504 +69	+0.8%	+$3.76K	﹤0.01%	730
2025 Q3	$457K	Buy	8,435 +3,354	+66%	+$192K	﹤0.01%	768
2025 Q2	$279K	Buy	5,081 +62	+1%	+$3.65K	﹤0.01%	951
2025 Q1	$355K	Sell	5,019 -81	-2%	-$5.45K	﹤0.01%	766
2024 Q4	$335K	Hold	5,100	–	–	﹤0.01%	824
2024 Q3	$358K	Buy	+5,100	New	+$426K	﹤0.01%	828
2022 Q1	–	Sell	-4,830	Closed	-$427K	–	842
2021 Q4	$427K	Buy	4,830 +58	+1%	+$4.79K	﹤0.01%	596
2021 Q3	$369K	Buy	+4,772	New	+$377K	﹤0.01%	646
2020 Q3	–	Sell	-2,618	Closed	-$323K	–	828
2020 Q2	$323K	Sell	2,618 -289	-10%	-$28.7K	﹤0.01%	535
2020 Q1	$246K	Buy	+2,907	New	+$250K	﹤0.01%	579